A new study by the University of Turku and Turku University Hospital, Finland, found that a significant proportion of Parkinson's disease diagnoses are later corrected. Up to one in six diagnoses ...

Multicancer detection tests had sensitivity from 0.095 to 0.998, specificity from 0.657 to 1.0, and area under the receiver ...

Researchers at Dana-Farber Cancer Institute have developed a groundbreaking diagnostic tool that could transform the way ...

A study found that a significant proportion of Parkinson's disease diagnoses are later corrected. Up to one in six diagnoses changed after ten years of follow-up, and the majority of new diagnoses ...

Blinklab Limited (AU:BB1) has released an update. BlinkLab Limited is partnering with Bates College to conduct a clinical study on their new smartphone-based test for diagnosing Functional ...

About this issue Abstract OBJECTIVE To evaluate the performance of diagnostic prediction models for ovarian malignancy in all patients with an ovarian mass managed surgically or conservatively. DESIGN ...

For the study, researchers analyzed data on 286 patients referred by primary care practices to Mayo Clinic’s General Internal Medicine Division from Jan. 1, 2009 to Dec. 31, 2010. The study found only ...

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians.

Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...

PITTSBURGH (KDKA) — Researchers in Pittsburgh are proposing a diagnostic tool that could change the game for health professionals and patients. The hope is that the small but mighty device dreamed up ...